WE ARE INNOVATIVE
The emergence of genomic technologies, such as next-generation sequencing (NGS), enables the industry and academic environment to offer products and services, which allows doctors to interpret patient data using technologies for complex intelligent analysis of clinical information in real time.
WE ALWAYS USE ONLY THE LATEST DATA
ONCOGENE offers personalized, structured medical reports of cancer patients, containing information of the detected genetic mutations of the tumour, complex contexts of interaction between individual mutations, mechanisms of disease, all types of genomic changes, potentially effective and potentially ineffective anticancer drugs, data on their toxicity, adverse events and drug interactions etc.
WE GUARANTEE THE ACCURACY AND QUALITY
Medical reports are generated using a diagnostic device (software) MH Guide® (CE-IVD), registered in Europe, which is intended for clinical interpretation of genomic data of patient's tumour, and obtained as a result of whole-exome sequencing of DNA tumour. Information contained in the report, and intended for medical oncologist, is the result of complex comparative analysis of genomic profile of the tumour of specific patient with relevant global biomedical and pharmacological data and knowledge.
WE GUARANTEE THE SECURITY OF PATIENT DATA
ONCOGENE guarantees the use of genetic information only in the interest of the patient. This is achieved by implementing and using of standards for the transmission of genetic information. ONCOGENE guarantees the patient's right to be informed and make decisions about the results of genetic testing, as well as complete confidentiality.